Related Experiment Video
Updated: Jun 28, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Hypertrophic cardiomyopathy: current understanding and treatment objectives
1Department of Pathology, Toronto General Hospital/University Health Network, Toronto, Canada.
Insights
Hypertrophic cardiomyopathy (HCM) is a genetic heart condition caused by sarcomeric gene mutations. Early identification and research into genetic basis and therapies are crucial for optimizing patient care and preventing complications.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Hypertrophic cardiomyopathy (HCM) is increasingly understood as a genetic disorder.
- Mutations in cardiac sarcomeric genes are the primary cause of HCM.
- HCM presents significant risks including outflow tract obstruction, diastolic dysfunction, arrhythmias, stroke, infective endocarditis, and sudden cardiac death.
Purpose of the Study:
- To summarize the current understanding of hypertrophic cardiomyopathy (HCM).
- To provide insights into appropriate diagnostic investigations for HCM patients.
- To outline current treatment strategies for individuals with HCM.
Main Methods:
- This is a review article.
- It synthesizes current knowledge on HCM.
- It discusses diagnostic and therapeutic approaches.
Main Results:
- HCM is a genetically determined cardiac disease.
- Early diagnosis and management are critical due to severe potential complications.
- Knowledge gaps remain regarding the full genetic basis and optimal therapeutic strategies.
Conclusions:
- Continued research into the genetic underpinnings of HCM is essential.
- Further assessment of therapeutic strategies is needed to improve patient outcomes.
- Optimizing patient care requires a comprehensive approach integrating genetic understanding, diagnostics, and treatment.
Abstract:
The understanding of hypertrophic cardiomyopathy (HCM) has changed dramatically over the last few decades, and it is now understood to be caused by a mutation in one of several cardiac sarcomeric genes. Due to complications such as outflow tract obstruction, diastolic dysfunction, arrhythmias, stroke, infective endocarditis and sudden cardiac death, appropriate and early identification of these patients is imperative. This review attempts to summarise the current state of knowledge on HCM, and provide insight of the appropriate investigations needed in patients with HCM. It also outlines treatment strategies for these patients. Much remains unknown about this complex and intriguing disease, and continued research in identifying the genetic basis of HCM, along with the assessment of therapeutic strategies, will help to optimise patient care.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy VI: Nursing Management

